SCHEMBL9180769

SCHEMBL9180769

CCOc1cc(-c2ccc(Cl)nn2)ccc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.48
MAPT P10636 5/20 0.44
ALDH1A1 P00352 5/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
S1PR1 P21453 2/20 0.44
S1PR3 Q99500 1/20 0.44
USP2 O75604 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
FPR2 P25090 2/20 0.42
KDM4E B2RXH2 3/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
KCNH2 Q12809 1/20 0.41
ERN1 O75460 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9183532 0.94 SMN1; SMN2 (0.48) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL9325859 0.89 FPR2 (0.47) MAPTALDH1A1MEN1KMT2AFPR2
SCHEMBL1744281 0.88 MEN1 (0.53) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL9186302 0.85 XDH (0.47) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL9185101 0.84 PDE4D (0.43) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL9182543 0.84 DHODH (0.43) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL9179120 0.83 MAPT (0.43) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL9181864 0.81 PDE4D (0.43) SMN1; SMN2MAPTALDH1A1MEN1KMT2A
SCHEMBL9186329 0.81 PDE4A (0.43) MAPTALDH1A1MEN1KMT2AUSP2
SCHEMBL9186261 0.80 PDE4B (0.43) SMN1; SMN2MAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0469013-B1 NOVEL ARYLPYRIDAZINES, THEIR MANUFACTURE, USE AND MEDICAMENTS CONTAINING THEM BYK GULDEN LOMBERG CHEM FAB (DE) 1995-06-28 EP disclosed
US-5236918-A Bronchial disorders BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1993-08-17 US disclosed
EP-0469013-A1 NOVEL ARYLPYRIDAZINES, THEIR MANUFACTURE, USE AND MEDICAMENTS CONTAINING THEM. BYK GULDEN LOMBERG CHEM FAB (DE) 1992-02-05 EP disclosed
WO-1990012789-A1 NOVEL ARYLPYRIDAZINES, THEIR MANUFACTURE, USE AND MEDICAMENTS CONTAINING THEM BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1990-11-01 WO disclosed
EP-0393500-A1 Arylpyridazines, their preparation, their use and pharmaceuticals containing them Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1990-10-24 EP disclosed
US-4707481-A Pyridazinones, their preparation and use, and bronchospasmolytic medicaments containing pyridazinones BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 1987-11-17 US disclosed
EP-0125636-B1 PYRIDAZINONES, THEIR PREPARATION AND USE, MEDICINES CONTAINING THESE PYRIDAZINONES Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1987-04-01 EP disclosed
WO-1984004521-A1 PYRIDAZINONES, THEIR PREPARATION AND USE, AND MEDICAMENTS CONTAINING PYRIDAZINONES BYK GULDEN LOMBERG CHEM FAB (DE) 1984-11-22 WO disclosed
EP-0125636-A1 Pyridazinones, their preparation and use, medicines containing these pyridazinones Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 1984-11-21 EP disclosed